Figure 3
The function of MICAL2 in evaluating the stromal component of pancreatic cancer. (A) The relationship between MICLA2 expression and Tumor purity of each pancreatic cancer sample in the TCGA (high MICAL2 expression group: 89, low expression MICAL2 group: 89). (B) The relationship between MICLA2 expression and stromal score of each pancreatic cancer sample in the TCGA (high MICAL2 expression group: 89, low expression MICAL2 group: 89). (C) Correlation analysis between MICAL2 and MMP2 in the TCGA dataset. (D) Representative immunohistochemical images of MICAL2 and MMP2 in pancreatic cancer (bar 100 μm). (E) The proportion of MMP2 expression grouped by MICAL2 high/low expression in our cohort (*p < 0.05).
